4
Changes in Ownership
Merck & Co., Inc. Filed Acc 0001127602-24-005196
EVP & CFO sold 38,291 shares at $125.50 ($4,805,521)
- EVP & CFO acquired 38,291 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Litchfield Caroline EVP & CFO | 2024-02-14 | Option exercise | +38,291 | $58.08 | $2,223,941 | 89,199.19 | D |
| Litchfield Caroline EVP & CFO | 2024-02-14 | Sale | −38,291 | $125.50 | $4,805,521 | 50,908.19 | D |
| Derivatives | |||||||
| Litchfield Caroline EVP & CFO | 2024-02-14 | Option exercise · Stock Option (Right to Buy) | −38,291 | 0 | D | ||
| Open-market sales · 38,291 sh · avg $125.50 · $4,805,521 | |||||||
Loading xslF345X05/form4.xml…